Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proteasome subunit beta 3 pseudogene 2 (PSMB3P2) is a human pseudogene, meaning it shares sequence similarity with the functional proteasome subunit beta 3 gene (PSMB3) but does not encode a functional protein and is not known to produce a functional RNA product[5]. Pseudogenes can sometimes regulate their protein-coding counterparts via non-coding RNA mechanisms (e.g., acting as microRNA decoys), but there is currently no evidence that PSMB3P2 performs such a function in humans[7]. It is not considered a receptor, enzyme, transporter, or transcription factor, and is not a recognized therapeutic target or biomarker in any disease context[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome subunit beta 3 pseudogene 2 (PSMB3P2).